Skip to main content
. 2013 Mar 6;9(1):8. doi: 10.1186/1710-1492-9-8

Table 3.

The association of asthma device use with demographic and clinical characteristics

Characteristics Levels Improper 203 (45%) Proper 247 (55%) P-value
Gender
Female
123(44.9)
151(55.1)
0.9066
Age
≥ 45 Years
82(49.7)
83(50.3)
0.1369
Follow up with doctor
Yes
94(34.8)
176(65.2)
0.0001*
 
No
109(60.9)
70(39.1)
 
Educational level
High school or less
173(44.7)
214(55.3)
0.5884
Education about medication
Yes
103(38.7)
163(61.3)
0.0009*
 
No
100(54.6)
83(45.4)
 
Education about asthma
Yes
71(32.7)
146(67.3)
0.0001*
 
No
132(56.9)
100(43.1)
 
ACT
Uncontrolled
62(59.1)
43(41.0)
0.0010*
Full/Partially controlled
140(40.8)
203(59.2)
 
ED visits
≥ 3
84(50.9)
81(49.1)
0.0497*
 
< 3
114(41.3)
162(58.7)
 
Duration of asthma
>1 Year
188(43.8)
241(56.2)
0.0046*
 
≤1 Year
14(77.8)
4(22.2)
 
Received health education about asthma disease from a physician
 
 
 
 
Yes
60(30.0)
140(70.0)
0.0001*
 
No
143(57.4)
106(42.6)
 
Received health education about asthma disease from a health educator
 
 
 
 
Yes
14(40.0)
21(60.0)
0.5188
 
No
189(45.7)
225(54.4)
 
Received health education about asthma disease from a pharmacist
 
 
 
 
Yes
6(28.6)
15(71.4)
0.1166
 
No
197(46.0)
231(54.0)
 
Knew about asthma disease independently
 
 
 
 
Yes
11(40.7)
16(59.3)
0.6302
 
No
192(45.5)
230(54.5)
 
Device
MDI
189(45.7)
225(54.4)
0.6958
 
Turbuhaler
6(46.2)
7(53.9)
 
 
MDI with spacer
6(31.9)
13(68.4)
 
  Diskus 2(50.0) 2(50.0)  

*The Chi-square/Fisher exact statistic is significant at the .05 level.